Workup and Treatment for Suspected Gout
For patients with suspected acute gout, perform synovial fluid analysis with crystal identification when diagnostic testing is clinically indicated, and treat acute attacks immediately with corticosteroids, NSAIDs, or low-dose colchicine. 1, 2
Diagnostic Workup
Synovial Fluid Analysis - The Gold Standard
ACP recommends synovial fluid analysis when clinical judgment indicates diagnostic testing is necessary 1. This involves joint aspiration to identify monosodium urate (MSU) crystals under polarized microscopy, which remains the reference standard for diagnosis. However, this test is significantly underutilized in primary care, emergency departments, and even rheumatology practices 1.
When Synovial Fluid Analysis Is Not Available
If joint aspiration is not feasible, diagnosis can be made using:
- Clinical criteria from the American College of Rheumatology 3
- Combination of clinical presentation, laboratory findings, and imaging 4
- Look for: acute monoarticular arthritis (especially first metatarsophalangeal joint), rapid onset of severe pain, joint erythema and swelling, history of similar attacks, presence of tophi, hyperuricemia 1, 3
Critical pitfall: Serum uric acid levels can be normal during acute attacks, so don't rule out gout based on normal urate levels alone. Conversely, hyperuricemia alone doesn't confirm gout 1.
Treatment of Acute Gout
First-Line Anti-Inflammatory Therapy
ACP strongly recommends choosing between corticosteroids, NSAIDs, or colchicine to treat acute gout attacks 2. All three options have high-quality evidence supporting their efficacy.
Specific dosing for colchicine: When using colchicine, use low-dose regimens (strong recommendation, moderate-quality evidence) 2. Low-dose colchicine has a more favorable side effect profile compared to traditional high-dose regimens while maintaining similar efficacy 2, 5.
Treatment Selection Algorithm:
- NSAIDs: Use high-dose, short half-life NSAIDs with prompt initiation 6. Preferred over colchicine due to better tolerability 6
- Corticosteroids: Systemic or intra-articular options. Use when NSAIDs/colchicine are contraindicated due to comorbidities (renal disease, GI issues) 6. Intra-articular injections appropriate for mono- or oligoarticular involvement 6
- Colchicine: Low-dose regimen; reserve for patients who can tolerate it 2
Key principle: Start anti-inflammatory treatment immediately—early initiation is critical for successful outcomes 6.
Management of Recurrent Gout
When NOT to Start Urate-Lowering Therapy
ACP strongly recommends against initiating long-term urate-lowering therapy after a first gout attack or in patients with infrequent attacks 2. This is a strong recommendation based on moderate-quality evidence.
When to Consider Urate-Lowering Therapy
For patients with recurrent gout attacks, discuss benefits, harms, costs, and preferences before initiating urate-lowering therapy 2. The decision should be individualized based on attack frequency and patient values.
Urate-Lowering Strategy
- Target serum uric acid: Below 360 μmol/L (6.0 mg/dL) for all patients; below 300 μmol/L (5.0 mg/dL) for patients with tophi 4, 7
- First-line agents: Allopurinol and febuxostat are first-line medications 3
- Alternative agents: Colchicine and probenecid reserved for patients intolerant to or failing first-line therapy 3
Mandatory Flare Prophylaxis
When initiating any urate-lowering therapy, provide concurrent prophylaxis with NSAIDs, colchicine, or low-dose corticosteroids 2, 5, 3. Continue prophylaxis for:
- At least 3-6 months after starting urate-lowering therapy 4, 3
- At least 3 months after uric acid reaches target in patients without tophi 3
- 6 months in patients with history of tophi 3
This prophylaxis is universally recommended and critical to prevent acute flares when initiating urate-lowering therapy 5.
Non-Pharmacologic Management
Address modifiable risk factors:
- Limit: Organ meats, shellfish, alcoholic drinks (especially beer), beverages with high-fructose corn syrup 3
- Encourage: Vegetable consumption, low-fat or nonfat dairy products 3
- Medication review: Loop and thiazide diuretics increase uric acid; consider losartan as alternative antihypertensive (increases uric acid excretion) 3
- Weight loss and exercise 2
Critical Timing Considerations
Do not initiate urate-lowering therapy during an acute attack—wait until the attack fully resolves and patient is stable on prophylaxis 6. Treat the acute inflammation first, then address hyperuricemia as a separate phase of management.